Andersen JW - Search Results

1

Association between clonogenic cell growth and clinical risk group in B-cell chronic lymphocytic leukemia.

Dadmarz R, Rabinowe SN, Cannistra SA, Andersen JW, Freedman AS, Nadler LM. Dadmarz R, et al. Among authors: andersen jw. Blood. 1990 Jul 1;76(1):142-9. Blood. 1990. PMID: 2194588 Free article.

2

Anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation for B-cell non-Hodgkin's lymphoma: phenotypic reconstitution and B-cell function.

Pedrazzini A, Freedman AS, Andersen J, Heflin L, Anderson K, Takvorian T, Canellos GP, Whitman J, Coral F, Ritz J, et al. Pedrazzini A, et al. Blood. 1989 Nov 1;74(6):2203-11. Blood. 1989. PMID: 2478224 Free article.

3

Monoclonal antibody-purged bone marrow transplantation therapy for multiple myeloma.

Anderson KC, Andersen J, Soiffer R, Freedman AS, Rabinowe SN, Robertson MJ, Spector N, Blake K, Murray C, Freeman A, et al. Anderson KC, et al. Blood. 1993 Oct 15;82(8):2568-76. Blood. 1993. PMID: 8400304 Free article.

4

Monoclonal antibody-purged bone marrow transplantation therapy for multiple myeloma.

Seiden MV, Schlossman R, Andersen J, Freeman A, Robertson M, Soiffer R, Freedman A, Mauch P, Ritz J, Nadler L, et al. Seiden MV, et al. Leuk Lymphoma. 1995 Mar;17(1-2):87-93. doi: 10.3109/10428199509051707. Leuk Lymphoma. 1995. PMID: 7773166 Clinical Trial.

5

Gallium-67 imaging: a predictor of residual tumor viability and clinical outcome in patients with diffuse large-cell lymphoma.

Kaplan WD, Jochelson MS, Herman TS, Nadler LM, Stomper PC, Takvorian T, Andersen JW, Canellos GP. Kaplan WD, et al. Among authors: andersen jw. J Clin Oncol. 1990 Dec;8(12):1966-70. doi: 10.1200/JCO.1990.8.12.1966. J Clin Oncol. 1990. PMID: 2230889

6

Sources and sequelae of bacterial contamination of hematopoietic stem cell components: implications for the safety of hematotherapy and graft engineering.

Webb IJ, Coral FS, Andersen JW, Elias AD, Finberg RW, Nadler LM, Ritz J, Anderson KC. Webb IJ, et al. Among authors: andersen jw. Transfusion. 1996 Sep;36(9):782-8. doi: 10.1046/j.1537-2995.1996.36996420753.x. Transfusion. 1996. PMID: 8823450

7

Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with In vitro and In vivo chemoresponses.

Kitada S, Andersen J, Akar S, Zapata JM, Takayama S, Krajewski S, Wang HG, Zhang X, Bullrich F, Croce CM, Rai K, Hines J, Reed JC. Kitada S, et al. Blood. 1998 May 1;91(9):3379-89. Blood. 1998. PMID: 9558396 Free article.

8

Risk factors for high-dose cytarabine neurotoxicity: an analysis of a cancer and leukemia group B trial in patients with acute myeloid leukemia.

Rubin EH, Andersen JW, Berg DT, Schiffer CA, Mayer RJ, Stone RM. Rubin EH, et al. Among authors: andersen jw. J Clin Oncol. 1992 Jun;10(6):948-53. doi: 10.1200/JCO.1992.10.6.948. J Clin Oncol. 1992. PMID: 1588374 Clinical Trial.

9

Association of PML-RAR alpha fusion mRNA type with pretreatment hematologic characteristics but not treatment outcome in acute promyelocytic leukemia: an intergroup molecular study.

Gallagher RE, Willman CL, Slack JL, Andersen JW, Li YP, Viswanatha D, Bloomfield CD, Appelbaum FR, Schiffer CA, Tallman MS, Wiernik PH. Gallagher RE, et al. Among authors: andersen jw. Blood. 1997 Aug 15;90(4):1656-63. Blood. 1997. PMID: 9269786 Free article. Clinical Trial.

10

RAR alpha1/RAR alpha2-PML mRNA expression in acute promyelocytic leukemia cells: a molecular and laboratory-clinical correlative study.

Li YP, Andersen J, Zelent A, Rao S, Paietta E, Tallman MS, Wiernik PH, Gallagher RE. Li YP, et al. Blood. 1997 Jul 1;90(1):306-12. Blood. 1997. PMID: 9207466 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

95 results

Search Page

Filters